Table 1.
ACT test results by country of manufacture and World Health Organization approval status.
| Country of manufacture | Percent samples with <75% API* from WHO-approved manufacturers | Percent samples with <75% API from non-WHO-approved manufacturers | Percent total ACT samples with >50% and <75% API |
|---|---|---|---|
| China | 12.3% (7/57) | 13.5% (15/111) | 13.1% (22/168) |
| India | 4% (8/198) | 12.5% (13/104) | 7% (21/302) |
| EU/USA | 0.7% (3/429) | 5.4% (2/37) | 1.1% (5/466) |
| Other countries** | 13.1% (35/267) | 13.1% (35/267) | |
| Total | 2.6% (18/684) | 12.5% (65/519) | 6.9% (83/1203) |
* Active Pharmaceutical Ingredient ** Includes Vietnam, Nigeria, Kenya, Thailand, Tanzania and Uganda, in decreasing order of number of samples (all countries have at least 10 samples).